# Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

> **NCT06801418** · PHASE1 · COMPLETED · sponsor: **Mirati Therapeutics Inc.** · enrollment: 160 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Adagrasib

## Key facts

- **NCT ID:** NCT06801418
- **Lead sponsor:** Mirati Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-04
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-06-19
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06801418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06801418, "Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06801418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*